Safety and efficacy of sofosbuvir‐based treatment of acute hepatitis C in end‐stage renal disease patients undergoing haemodialysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|4|526-532

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.4, 2018-02, pp. : 526-532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Chronic Hepatitis C in Patients with End-Stage Renal Disease and Hemophilia – The Singapore Experience

By  

Intervirology, Vol. 49, Iss. 1-2, 2005-09 ,pp. : 107-111

Karger

Access to resources Recommend Favorite

Antibody Response to Hepatitis B Vaccine in End-Stage Renal Disease Patients

By  

Nephron Clin Pract, Vol. 103, Iss. 3, 2006-03 ,pp. : c89-c93

Karger

Access to resources Recommend Favorite

Risk of acute coronary syndrome after parathyroidectomy in patients with end‐stage renal disease: A population‐based cohort study in Taiwan

By  

NEPHROLOGY, Vol. 23, Iss. 2, 2018-02 ,pp. : 139-147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 1, 2014-03 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis and Treatment of Low Testosterone among Patients with End‐Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 3, 2015-05 ,pp. : 259-265

John Wiley & Sons Inc

Access to resources Recommend Favorite